En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
INNOSUISSE
Numéro de projet
13875.1;8 PFLS-LS
Titre du projet
From the Chemical Universe to Novel Drug Discovery
Titre du projet anglais
From the Chemical Universe to Novel Drug Discovery

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Description succincte
-
Anzeigen
-
Anzeigen
Résumé des résultats (Abstract)
-
Anzeigen
-
Anzeigen

Textes saisis


CatégorieTexte
Description succincte
(Anglais)
From the Chemical Universe to Novel Drug Discovery
Description succincte
(Français)
From the Chemical Universe to Novel Drug Discovery
Résumé des résultats (Abstract)
(Anglais)
HiQScreen is strategically interested in using its screening capacity in electrophysiology for direct drug discovery with the goal of accessing new small molecule drug candidates. This can be realized through a collaboration with Reymond group, which provides cutting-edge and innovative computer-aided drug design concepts and organic synthesis expertise. The combination of both expertise¿s offers a competitive advantage which we will apply to discovery new drugs for unmet medical needs.
Résumé des résultats (Abstract)
(Français)
HiQScreen is strategically interested in using its screening capacity in electrophysiology for direct drug discovery with the goal of accessing new small molecule drug candidates. This can be realized through a collaboration with Reymond group, which provides cutting-edge and innovative computer-aided drug design concepts and organic synthesis expertise. The combination of both expertise¿s offers a competitive advantage which we will apply to discovery new drugs for unmet medical needs.